----item----
version: 1
id: {DF5A3FC1-C562-44C9-B5E9-CD45D4DCD112}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/10/22/Medicines Patent Pool Adds Four Board Members
parent: {24491DE3-DC6F-4529-9855-F0E4CDE93C9E}
name: Medicines Patent Pool Adds Four Board Members
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: 4cb7198c-f6f2-462e-ad4a-02a6b735961d

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{9557EF58-727F-4007-9C73-6232F381DFF1}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 46

Medicines Patent Pool Adds Four Board Members 
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 45

Medicines Patent Pool Adds Four Board Members
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1119

<p>The Medicines Patent Pool has appointed four new board members; Claudia Chamas, Michel Manon, Brian Tempest and Jayashree Watal. Chamas is a senior researcher at Brazil's Oswaldo Cruz Foundation and has served as representative of the Ministry of Health at the Brazilian Interministerial Group on Intellectual Property and as vice-chair of the WHO Consultative Expert Working Group on research and development (CEWG). Manon, former director for Bristol-Myers Squibb, held various other senior roles at the company including medical director. Tempest was previously at Ranbaxy where he was CEO, managing director and regional director-Far East and regional-director-Middle East & Africa for GlaxoSmithKline (GSK). Currently Tempest is advisor to the United Nations Conference on trade and development and holds non-executive director status in various Indian healthcare and pharma companies. Watal is currently counsellor in the intellectual property division of the Word Trade Organization and has over 22 years' experience in the Indian government working on policy, diplomacy, research and IP rights issue. </p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1116

<p>The Medicines Patent Pool has appointed four new board members; Claudia Chamas, Michel Manon, Brian Tempest and Jayashree Watal. Chamas is a senior researcher at Brazil's Oswaldo Cruz Foundation and has served as representative of the Ministry of Health at the Brazilian Interministerial Group on Intellectual Property and as vice-chair of the WHO Consultative Expert Working Group on research and development (CEWG). Manon, former director for Bristol-Myers Squibb, held various other senior roles at the company including medical director. Tempest was previously at Ranbaxy where he was CEO, managing director and regional director-Far East and regional-director-Middle East & Africa for GlaxoSmithKline (GSK). Currently Tempest is advisor to the United Nations Conference on trade and development and holds non-executive director status in various Indian healthcare and pharma companies. Watal is currently counsellor in the intellectual property division of the Word Trade Organization and has over 22 years' experience in the Indian government working on policy, diplomacy, research and IP rights issue. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 45

Medicines Patent Pool Adds Four Board Members
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20151022T160001
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20151022T160001
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20151022T160001
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC030180
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 46

Medicines Patent Pool Adds Four Board Members 
----field----
field: {53288D3D-66D7-4ACE-B3E4-D7D02B1F3672}
name: Referenced Companies
key: referenced companies
content-length: 9

200200521
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{202BB75B-8718-40FC-96EC-851DBBB43362}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 11

Expert View
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

361183
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042514Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

4cb7198c-f6f2-462e-ad4a-02a6b735961d
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042514Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
